Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO CLINICAL BREAKTHROUGHS IN ORTHOPAEDICS

October 2022

ORTHOPAEDICS

TARGETING ION CHANNELS TO MANAGE OSTEOARTHRITIS PAIN

Featuring: Paul DeCaen, PhD
Therapeutically targeting ion channels in nociceptor neurons may be a promising strategy to manage osteoarthritis pain, according to a Northwestern Medicine study published in Cell Reports.

Paul DeCaen, PhD, associate professor of Pharmacology, was senior author of the study.

Nociceptor neurons transmit pain signals to the brain using electrical currents generated by voltage-gated sodium channels; when overactive, those channels are commonly observed in cases of osteoarthritis and other aberrant pain conditions.

Targeting the sodium channels to improve osteoarthritis pain management is been explored as a potential therapeutic strategy. Previous work from the DeCaen laboratory demonstrated that a metabolite of tamoxifen, an estrogen receptor modulator, binds to the intracellular exit of the channel, underscoring it’s therapeutic potential.

Despite the clear need, efforts in developing novel sodium channel blockers into real therapies has been challenging, according to DeCaen.
two drug receptor sites
The image depicts two drug receptor sites with the molecular structure of the Nav1.7 channel, and tamoxifen’s attenuation of nociceptor action potentials responsible for transmitting aberrant pain signals.
“Repurposing tamoxifen metabolites, commonly used to treat breast cancer, presents an alternative strategy which can bypass phase one clinical trials,” DeCaen said.

In the current study, DeCaen’s team administered a tamoxifen metabolite to mice that had been genetically modified to develop osteoarthritis symptoms. They found the drug bound to two intracellular receptor sites in sodium channels, blocking the entry of ions using a “bind and plug” mechanism and inhibiting sodium channels in inflamed, overactivated nociceptor neurons responsible for osteoarthritic pain.

“To our knowledge, clinical efficacy of tamoxifen metabolites for osteoarthritic pain treatment is untested. Yet many years of oncology clinical data significantly de-risks their use, which may lower overall development costs for their use to treat osteoarthritic pain,” DeCaen said.

Megan Larmore and Eduardo Guadarrama, students in the Driskill Graduate Program in Life Sciences (DGP), and Thuy Vien, PhD, research assistant professor of Pharmacology, were co-authors of the study.

This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases grant 1R01 DK123463-01 and National Institute of General Medical Sciences grant 5T32 GM008382.

This article was originally published in the Feinberg School of Medicine News Center on October 4, 2022.
Headshot of Paul DeCaen, PhD
Paul DeCaen, PhD, associate professor of Pharmacology, was senior author of the study published in Cell Reports.

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​
Call 844.344.6663
Find an NM Orthopaedic Specialist

You May Also Like

Headshot of Dr. Ben Butler

February 2022

ORTHOPAEDICS
Complex Pelvis and Hip Reconstruction
Headshot of Dr. Linda Suleiman

November 2021

ORTHOPAEDICS
Inside the OR: Robotic Assisted Knee Replacement
Video still of Dr. Lucas Buchler with black background

September 2021

ORTHOPAEDICS
Professional Baseball and Orthopaedic Injuries

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties